153 related articles for article (PubMed ID: 32112669)
21. A two-stage sample size recalculation procedure for placebo- and active-controlled non-inferiority trials.
Schwartz TA; Denne JS
Stat Med; 2006 Oct; 25(19):3396-406. PubMed ID: 16900573
[TBL] [Abstract][Full Text] [Related]
22. Non-parametric assessment of non-inferiority with censored data.
Freitag G; Lange S; Munk A
Stat Med; 2006 Apr; 25(7):1201-17. PubMed ID: 16345041
[TBL] [Abstract][Full Text] [Related]
23. On non-inferiority analysis based on delta-method confidence intervals.
Rothmann MD; Tsou HH
J Biopharm Stat; 2003 Aug; 13(3):565-83. PubMed ID: 12921402
[TBL] [Abstract][Full Text] [Related]
24. Conducting the non-inferiority test for the means with unknown coefficient of variation in a three-arm trial.
Lee MC; Wu WY; Lu HY; Hsieh HN; Wu WH
BMC Med Res Methodol; 2023 Aug; 23(1):183. PubMed ID: 37568109
[TBL] [Abstract][Full Text] [Related]
25. Construction of confidence intervals for the risk differences in stratified design with correlated bilateral data.
Qiu SF; Poon WY; Tang ML; Tao JR
J Biopharm Stat; 2019; 29(3):446-467. PubMed ID: 30933654
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
Tsong Y; Zhang J
J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
[TBL] [Abstract][Full Text] [Related]
27. Approaches for testing noninferiority in two-arm trials for risk ratio and odds ratio.
Chowdhury S; Tiwari RC; Ghosh S
J Biopharm Stat; 2019; 29(3):425-445. PubMed ID: 30744476
[TBL] [Abstract][Full Text] [Related]
28. The assessment of non-inferiority in a gold standard design with censored, exponentially distributed endpoints.
Mielke M; Munk A; Schacht A
Stat Med; 2008 Nov; 27(25):5093-110. PubMed ID: 18570271
[TBL] [Abstract][Full Text] [Related]
29. TACT method for non-inferiority testing in active controlled trials.
Wang SJ; Hung HM
Stat Med; 2003 Jan; 22(2):227-38. PubMed ID: 12520559
[TBL] [Abstract][Full Text] [Related]
30. New approaches for testing non-inferiority for three-arm trials with Poisson distributed outcomes.
Ghosh S; Paul E; Chowdhury S; Tiwari RC
Biostatistics; 2022 Jan; 23(1):136-156. PubMed ID: 32385495
[TBL] [Abstract][Full Text] [Related]
31. A ratio test in active control non-inferiority trials with a time-to-event endpoint.
Wang YC; Chen G; Chi GY
J Biopharm Stat; 2006; 16(2):151-64. PubMed ID: 16584064
[TBL] [Abstract][Full Text] [Related]
32. Non-inferiority test for a continuous variable with a flexible margin in an active controlled trial: an application to the "Stratall ANRS 12110 / ESTHER" trial.
Sandie AB; Molinari N; Wanjoya A; Kouanfack C; Laurent C; Tchatchueng-Mbougua JB
Trials; 2022 Mar; 23(1):202. PubMed ID: 35248123
[TBL] [Abstract][Full Text] [Related]
33. A more efficient three-arm non-inferiority test based on pooled estimators of the homogeneous variance.
Lu H; Jin H; Zeng W
Stat Methods Med Res; 2018 Aug; 27(8):2437-2446. PubMed ID: 27920362
[TBL] [Abstract][Full Text] [Related]
34. Confidence intervals of the difference between areas under two ROC curves in matched-pair experiments.
Zhang Y; Tang N
Stat Med; 2020 Sep; 39(20):2621-2638. PubMed ID: 32390284
[TBL] [Abstract][Full Text] [Related]
35. Comments on 'Planning and analysis of three-arm non-inferiority trials with binary endpoints' by M. Kieser and T. Friede, Statistics in Medicine 2007; 26:253-273.
Li G
Stat Med; 2011 Feb; 30(3):298-9; author reply 300. PubMed ID: 21213345
[No Abstract] [Full Text] [Related]
36. Some practical considerations in three-arm non-inferiority trial design.
Zhou M; Kundu S
Pharm Stat; 2016 Nov; 15(6):550-559. PubMed ID: 27681603
[TBL] [Abstract][Full Text] [Related]
37. Mixed noninferiority margin and statistical tests in active controlled trials.
Tsou HH; Hsiao CF; Chow SC; Yue L; Xu Y; Lee S
J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228
[TBL] [Abstract][Full Text] [Related]
38. Use of the Fieller-Hinkley distribution of the ratio of random variables in testing for noninferiority.
Koti KM
J Biopharm Stat; 2007; 17(2):215-28. PubMed ID: 17365219
[TBL] [Abstract][Full Text] [Related]
39. Study duration for three-arm non-inferiority survival trials designed for accrual by cohorts.
Wu Y; Li Y; Hou Y; Li K; Zhou X
Stat Methods Med Res; 2018 Feb; 27(2):507-520. PubMed ID: 26994213
[TBL] [Abstract][Full Text] [Related]
40. Some essential considerations in the design and conduct of non-inferiority trials.
Fleming TR; Odem-Davis K; Rothmann MD; Li Shen Y
Clin Trials; 2011 Aug; 8(4):432-9. PubMed ID: 21835862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
